Is Carter's (CRI) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Carter's Retail Momentum Builds: Can Comparable Sales Stay Strong?
CRI's retail momentum strengthens with rising sales, digital engagement and baby category growth driving positive comps.
Carter's Shares Rise 5% Post Q4 Earnings: What Should You Know?
CRI stock rises after a Q4 beat as sales climbed 7.6%, fueled by strong e-commerce demand, higher store traffic and growth across retail, wholesale and international.
Carter's (CRI) Upgraded to Strong Buy: What Does It Mean for the Stock?
Carter's (CRI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Should Value Investors Buy Carter's (CRI) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Value Stocks to Buy for March 2nd
ECPG, UVE and CRI made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 2, 2026.
Best Income Stocks to Buy for March 2nd
CZNC, UCB and CRI made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 2, 2026.
Carter's, Inc. (CRI) Q4 2025 Earnings Call Transcript
Carter's, Inc. (CRI) Q4 2025 Earnings Call Transcript
Carter's Q4 Earnings Beat Estimates, Shares Fall on Soft EPS View
CRI tops Q4 estimates with 7.6% sales growth, but stock sinks over 15% on soft Q1 and 2026 earnings outlook.
Carter's Gross Margins Show Challenges With Pricing Power
Carter's, Inc. reported Q4 results with solid top-line growth but significant margin deterioration due to tariffs and higher costs. FY26 guidance projects modest revenue growth driven by pricing, but persistent gross margin pressure and higher interest expense will weigh on net income. CRI trades at 10x forward earnings, yet secular headwinds like declining fertility and inability to offset tariffs undermine the investment case.
Carter's (CRI) Q4 Earnings and Revenues Surpass Estimates
Carter's (CRI) came out with quarterly earnings of $1.9 per share, beating the Zacks Consensus Estimate of $1.7 per share. This compares to earnings of $2.39 per share a year ago.
Is Carter's (CRI) Stock Outpacing Its Consumer Discretionary Peers This Year?
Here is how Carter's (CRI) and Dolby Laboratories (DLB) have performed compared to their sector so far this year.
